in the present study we substituted cyclophosphamide with ifosfamide in the combination cmf ( cyclophosphamide , methotrexate , and 5-fluorouracil ) regimen in 25 patients with breast cancer whose disease was refractory to cmf or who had relapsed after previous response .
C0010583
cyclophosphamide
C0950521
cmf